Teladoc Health
TDOC
371 hedge funds and large institutions have $5.74B invested in Teladoc Health in 2019 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 158 increasing their positions, 88 reducing their positions, and 50 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 158 | Existing positions reduced: 88
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
30% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 50
21% more capital invested
Capital invested by funds: $4.74B → $5.74B (+$997M)
2% more funds holding
Funds holding: 364 → 371 (+7)
0.68% more ownership
Funds ownership: 120.41% → 121.08% (+0.68%)
42% less call options, than puts
Call options by funds: $50.7M | Put options by funds: $87.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$36.4M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$34.3M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$33.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$33.3M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$32.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$203M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$50.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.4M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$24.3M |
| 5 |
Millennium Management
New York
|
-$12M |
TDOC Hedge Fund Activity: Q2 2019 in Review
371 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q2 2019, worth a combined $5.74B — up 21% from $4.74B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new TDOC positions and 50 closed out — a net gain of 15 holders — while 158 added to existing stakes and 88 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $36.4M. The largest seller was Fidelity Investments, cutting an estimated $203M.
- 371 institutional investors held Teladoc Health (TDOC) as of Q2 2019, up from 364 in Q1 2019.
- Funds reported $5.74B of Teladoc Health stock for Q2 2019, up 21% quarter-over-quarter.
- 65 funds opened new Teladoc Health positions in Q2 2019 and 50 closed out, a net change of +15 holders.
- The largest Teladoc Health buyer in Q2 2019 was JP Morgan Chase, an estimated $36.4M added.
- The largest Teladoc Health seller in Q2 2019 was Fidelity Investments, an estimated $203M sold.
Based on aggregated 13F filings for Q2 2019.